Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer
Status:
Completed
Trial end date:
2008-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of continued administration
of paclitaxel given weekly in subjects considered to need to continue treatment after
completion of the preceding "Phase II Clinical Study of Weekly Paclitaxel (BMS-181339) with
Advanced Breast Cancer (Protocol No. CA139-371)"